Category: Cancer Treatment
Cancer Treatment market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Fecal Occult Blood Tests for In-Vitro Colorectal Cancer Screenings
The 2025-2030 World Outlook for Fecal Occult Blood Tests for In-Vitro Colorectal Cancer Screenings This study covers the world outlook for fecal occult blood tests for in-vitro colorectal cancer screenings across more than 190 countries. For each year reported, estimates are given for the latent dem ... Read More
-
The 2025-2030 World Outlook for Central Nervous System Lymphoma
The 2025-2030 World Outlook for Central Nervous System Lymphoma This study covers the world outlook for central nervous system lymphoma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Cervical Cancer Diagnostic Testing
The 2025-2030 World Outlook for Cervical Cancer Diagnostic Testing This study covers the world outlook for cervical cancer diagnostic testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
-
The 2025-2030 World Outlook for Non-Hematological Cancer Treatments
The 2025-2030 World Outlook for Non-Hematological Cancer Treatments This study covers the world outlook for non-hematological cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma This study covers the world outlook for non-Hodgkin lymphoma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Treatments
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Treatments This study covers the world outlook for non-Hodgkin lymphoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Photopheresis Products
The 2025-2030 World Outlook for Photopheresis Products This study covers the world outlook for photopheresis products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Sarcoma Drugs
The 2025-2030 World Outlook for Sarcoma Drugs This study covers the world outlook for sarcoma drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), t ... Read More
-
The 2025-2030 World Outlook for Diagnostic Tests for Cervical Dysplasia
The 2025-2030 World Outlook for Diagnostic Tests for Cervical Dysplasia This study covers the world outlook for diagnostic tests for cervical dysplasia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
-
The 2025-2030 World Outlook for Next Generation Cancer Diagnostics
The 2025-2030 World Outlook for Next Generation Cancer Diagnostics This study covers the world outlook for next generation cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
-
The 2025-2030 World Outlook for Particle Therapies
The 2025-2030 World Outlook for Particle Therapies This study covers the world outlook for particle therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Stomach and Gastric Cancer Treatments
The 2025-2030 World Outlook for Stomach and Gastric Cancer Treatments This study covers the world outlook for stomach and gastric cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
-
The 2025-2030 World Outlook for Cancer Diagnostics Laboratory Tests
The 2025-2030 World Outlook for Cancer Diagnostics Laboratory Tests This study covers the world outlook for cancer diagnostics laboratory tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Imaging Devices
The 2025-2030 World Outlook for Breast Cancer Imaging Devices This study covers the world outlook for breast cancer imaging devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Ovarian Cancer Diagnostics
The 2025-2030 World Outlook for Ovarian Cancer Diagnostics This study covers the world outlook for ovarian cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Ovarian Cancer Drugs
The 2025-2030 World Outlook for Ovarian Cancer Drugs This study covers the world outlook for ovarian cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Blood Cancer Therapeutics
The 2025-2030 World Outlook for Blood Cancer Therapeutics This study covers the world outlook for blood cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Tumor-Specific Antigen
The 2025-2030 World Outlook for Tumor-Specific Antigen This study covers the world outlook for tumor-specific antigen across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for 3D Cell Cultures for Cancer and Stem Cell Research
The 2025-2030 World Outlook for 3D Cell Cultures for Cancer and Stem Cell Research This study covers the world outlook for 3D cell cultures for cancer and stem cell research across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earni ... Read More
-
The 2025-2030 World Outlook for Cancer Screenings
The 2025-2030 World Outlook for Cancer Screenings This study covers the world outlook for cancer screenings across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Cancer Supportive Care
The 2025-2030 World Outlook for Cancer Supportive Care This study covers the world outlook for cancer supportive care across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Cancer Stem Cells
The 2025-2030 World Outlook for Cancer Stem Cells This study covers the world outlook for cancer stem cells across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Hodgkins Lymphoma Drugs
The 2025-2030 World Outlook for Hodgkins Lymphoma Drugs This study covers the world outlook for Hodgkins lymphoma drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Angiogenesis Inhibitors and Stimulators
The 2025-2030 World Outlook for Angiogenesis Inhibitors and Stimulators This study covers the world outlook for angiogenesis inhibitors and stimulators across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
-
The 2025-2030 World Outlook for Bone Metastasis
The 2025-2030 World Outlook for Bone Metastasis This study covers the world outlook for bone metastasis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
Research Assistance
